Leading science, pioneering therapies
CRM Publications

Derivation of the clinical grade human embryonic stem cell line RCe013-A (RC-9).

TitleDerivation of the clinical grade human embryonic stem cell line RCe013-A (RC-9).
Publication TypeJournal Article
Year of Publication2016
Authorsde Sousa PA, Tye BJ, Bruce K, Dand P, Russell G, Collins DM, Greenshields A, McDonald K, Bradburn H, Canham MA, Kunath T, Downie JM, Bateman M, Courtney A
JournalStem Cell Res
Volume17
Issue1
Pagination36-41
Date Published2016 May 06
ISSN1876-7753
Abstract

The human embryonic stem cell line RCe013-A (RC-9) was derived under quality assured compliance with UK regulation, European Union Directives and International guidance for tissue procurement, processing and storage according to Good Manufacturing Practice (GMP) standards. The cell line was derived from a failed to fertilise oocyte voluntarily donated as unsuitable and surplus to fertility requirements following informed consent. RCe013-A (RC-9) shows normal pluripotency marker expression and differentiation to the three germ layers in vitro and in vivo. It has a normal 46XY male karyotype and microsatellite PCR identity, HLA and blood group typing data are available.

DOI10.1016/j.scr.2016.04.020
Alternate JournalStem Cell Res
PubMed ID27558601
Publication institute
CRM